id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-5319-0008,FDA,FDA-2017-N-5319,Transcript Part 15 Hearing Devices Referencing Drugs to Dockets Management,Other,Transcript(s),2018-01-26T05:00:00Z,2018,1,2018-01-26T05:00:00Z,,2018-01-26T18:58:40Z,,0,0,0900006482e6ddcc
FDA-2017-N-5319-0007,FDA,FDA-2017-N-5319,"Devices Proposed for a New Use With an Approved, Marketed Drug; Public Hearing; Reopening of the Comment Period",Proposed Rule,Extension of Comment Period,2018-01-22T05:00:00Z,2018,1,2018-01-22T05:00:00Z,2018-02-22T04:59:59Z,2018-02-24T02:01:42Z,2018-00991,0,0,0900006482e3eea7